Equibles does not estimate personal net worth.
Get an email with a short summary when Alnylam Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get ALNY alertsJohn Kennedy has spoken on 1 investor event across 1 company, most recently for Alnylam Pharmaceuticals, Inc. on September 8, 2026. Alnylam Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Alnylam Pharmaceuticals, Inc. includes Yvonne Greenstreet (CEO and COO), Yvonne L. Greenstreet (CEO, COO and Board Member), Amy W. Schulman (Chairman and Board Member) and 7 others.
“Yeah, for what we're looking at for the initiations of AmVutra, what we're seeing is it is still very balanced across these centers of excellence and the community.”
Transcript header (unverified)
Biotechnology · Healthcare
